Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TXNL4AP1 (TXNL4A pseudogene 1) is a non-functional genomic DNA sequence on chromosome 2 that closely resembles the TXNL4A gene. Unlike its parent gene, it does not encode a functional protein and has no known involvement in cellular processes, disease pathogenesis, or drug interaction. TXNL4AP1 should not be confused with TXNL4A (Thioredoxin-like protein 4A), which is an established spliceosome-associated protein involved in pre-mRNA splicing and associated with disorders such as Burn-McKeown syndrome[1][5][6]. If you intended the functional gene, please refer to Thioredoxin-like 4A (TXNL4A). Otherwise, TXNL4AP1 provides no actionable biological, therapeutic, or diagnostic information.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on TXNL4A pseudogene 1 (TXNL4AP1).